Cargando…

CITN11-02 interim trial results: subcutaneous administration of recombinant human IL-15 (rhil-15) is associated with robust expansion of peripheral blood CD56+ NK cells

Detalles Bibliográficos
Autores principales:	Morishima, Chihiro, McNeel, Douglas G, Patel, Manish R, Kohrt, Holbrook, Waldmann, Thomas A, Thompson, John A, Conlon, Kevin, M Sondel, Paul, Wakelee, Heather, Disis, Mary L, Creekmore, Stephen P, Miller, Jeffrey S
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4288749/ http://dx.doi.org/10.1186/2051-1426-2-S3-P80

Ejemplares similares

CITN11-02 interim trial results: subcutaneous administration of recombinant human IL-15 (rhIL-15) is associated with expansion of peripheral blood CD56+ NK cells and CD8+ T cells
por: Morishima, Chihiro, et al.
Publicado: (2015)

CITN-06: a Phase I/expansion trial of alt-803, an IL-15 superagonist, in patients with advanced melanoma
por: Margolin, Kim, et al.
Publicado: (2014)

Preliminary validation of nCounter PanCancer immune profiling of FFPE slides and pbmc in CITN-05, a CITN study of the immunological effects of an IDO1 inhibitor in patients with ovarian carcinoma
por: Dennis, Lucas, et al.
Publicado: (2015)

NKTR-255, a novel polymer-conjugated rhIL-15 with potent antitumor efficacy
por: Miyazaki, Takahiro, et al.
Publicado: (2021)

IL-15 in the Combination Immunotherapy of Cancer
por: Waldmann, Thomas A., et al.
Publicado: (2020)

His-tag ELISA for the detection of humoral tumor-specific immunity
por: Goodell, Vivian, et al.
Publicado: (2008)

Interleukin-15 (dys)regulation of lymphoid homeostasis: Implications for therapy of autoimmunity and cancer
por: Waldmann, Thomas A., et al.
Publicado: (2019)

Agenda for the 56th meeting on 15 Jan 2002
por: CERN. Geneva
Publicado: (2002)

Interleukin-15 augments NK cell–mediated ADCC of alemtuzumab in patients with CD52(+) T-cell malignancies
por: Miljkovic, Milos D., et al.
Publicado: (2022)

Targeting the interleukin-15/interleukin-15 receptor system in inflammatory autoimmune diseases
por: Waldmann, Thomas A
Publicado: (2004)

First-in-human phase I/Ib study of NIZ985, a recombinant heterodimer of IL-15 and IL-15Rα, as a single agent and in combination with spartalizumab in patients with advanced and metastatic solid tumors
por: Leidner, Rom, et al.
Publicado: (2023)

Decisions taken at the 56th meeting held on 15 January 2002
por: Landua, R, et al.
Publicado: (2002)

Experimental inoculation of chicken broilers with C. gallinacea strain 15-56/1
por: Szymańska-Czerwińska, Monika, et al.
Publicado: (2021)

Clinical and Immunological Effects of rhIL-2 Therapy in Eastern Chinese Patients with Multidrug-resistant Tuberculosis
por: Tan, Qi, et al.
Publicado: (2017)

Protein and Signaling Pathway Responses to rhIL-6 Intervention Before Lobaplatin Treatment in Osteosarcoma Cells
por: Wang, Huan, et al.
Publicado: (2021)

Minutes of the QCD meeting held on 15 02 94 (DPG talks)
por: Cowan, G
Publicado: (1994)

CPS94-RF #4 Réunion du 15/02/94
por: Garoby, R
Publicado: (1994)

CS15-02 Current Japanese Strategies for Preventing HCC Development
por: Ueno, Yoshiyuki
Publicado: (2009)

Identification of a Recombinant Human Interleukin-12 (rhIL-12) Fragment in Non-Reduced SDS-PAGE
por: Yu, Lei, et al.
Publicado: (2019)

Phase I study of single agent NIZ985, a recombinant heterodimeric IL-15 agonist, in adult patients with metastatic or unresectable solid tumors
por: Conlon, Kevin, et al.
Publicado: (2021)

Tracking the uptake and trajectory of COVID-19 vaccination coverage in 15 West African countries: an interim analysis
por: Afolabi, Muhammed Olanrewaju, et al.
Publicado: (2021)

Administration of rhIL-7 in humans increases in vivo TCR repertoire diversity by preferential expansion of naive T cell subsets
por: Sportès, Claude, et al.
Publicado: (2008)

Pharmacokinetic Study of rhIL-18BP and Its Effect on Radiation-Induced Cytokine Changes in Mouse Serum and Intestine
por: Cui, Wanchang, et al.
Publicado: (2022)

Differential IFN-γ production by adult and neonatal blood CD56(+) natural killer (NK) and NK-like-T cells in response to Trypanosoma cruzi and IL-15
por: Guilmot, A, et al.
Publicado: (2014)

Quantitative phosphoproteomic analysis reveals chemoresistance-related proteins and signaling pathways induced by rhIL-6 in human osteosarcoma cells
por: Zhang, Rui, et al.
Publicado: (2021)

HLA-B*15:02 genotype associated with hypersensitivity syndrome to lamotrigine in Thai population
por: Koomdee, Napatrupron, et al.
Publicado: (2014)

Interleukin 15 Pharmacokinetics and Consumption by a Dynamic Cytokine Sink
por: Hangasky, John A., et al.
Publicado: (2020)

Automation of [(18)F]fluoroacetaldehyde synthesis: application to a recombinant human interleukin‐1 receptor antagonist (rhIL‐1RA)
por: Morris, Olivia, et al.
Publicado: (2016)

Anti-myeloma efficacy of CAR-iNKT is enhanced with a long-acting IL-7, rhIL-7-hyFc
por: O’Neal, Julie, et al.
Publicado: (2023)

The contrasting roles of IL-2 and IL-15 in the life and death of lymphocytes: implications for the immunotherapy of rheumatological diseases
por: Waldmann, Thomas
Publicado: (2002)

Synthesis of 2,6-trans-disubstituted 5,6-dihydropyrans from (Z)-1,5-syn-endiols
por: Flamme, Eric M, et al.
Publicado: (2005)

8-Chloro-5,5-dimethyl-5,6-dihydrotetrazolo[1,5-c]quinazoline
por: Fun, Hoong-Kun, et al.
Publicado: (2010)

CD56 Homodimerization and Participation in Anti-Tumor Immune Effector Cell Functioning: A Role for Interleukin-15
por: Van Acker, Heleen H., et al.
Publicado: (2019)

PC56. Evaluating Facelift Complications and the Effectiveness of the Smasectomy Technique: A Single Center’S 15-year Experience
por: Shauly, Orr, et al.
Publicado: (2023)

2015 European School of High-Energy Physics: Bansko, Bulgaria 02 - 15 Sep 2015
por: Mulders, Martijn, et al.
Publicado: (2017)

Arthroplasty for tenosynovial giant cell tumors: 17 patients followed for 0.2 to 15 years
por: Verspoor, Floortje G M, et al.
Publicado: (2016)

OR15-02 Mental Health Implications and Determinants of When Youth Present to a Gender Clinic
por: Sorbara, Julia, et al.
Publicado: (2020)

Leukemia/lymphoma development in IL-15-deficient TCR-transgenic mice
por: Dubois, Sigrid, et al.
Publicado: (2015)

Short-course IL-15 given as a continuous infusion led to a massive expansion of effective NK cells: implications for combination therapy with antitumor antibodies
por: Dubois, Sigrid P, et al.
Publicado: (2021)

Vaccination with Tumor Cells Expressing IL-15 and IL-15Rα Inhibit Murine Breast and Prostate Cancer
por: Morris, John C., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_e7hd4ri0bh2vadbmaqptf2am3d